Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy
AIDS, Volume 25, No. 5, Year 2011
Notification
URL copied to clipboard!
Description
Objective: To examine if there is a significant difference in survival between elderly (>50 years) and nonelderly adult patients receiving combination antiretroviral therapy in Uganda between 2004 and 2010. Design: Prospective observational study. Methods: Patients 18-49 years of age (nonelderly) and 50 years of age and older enrolled in the AIDS Support Organization Uganda HIV/AIDS national programme were assessed for time to all-cause mortality. We applied a Weibull multivariable regression. Results: Among the 22 087 patients eligible for analyses, 19 657 (89.0%) were aged between 18 and 49 years and 2430 (11.0%) were aged 50 years or older. These populations differed in terms of the distributions of sex, baseline CD4 + cell count and death. The age group 40-44 displayed the lowest crude mortality rate [31.4 deaths per 1000 person-years; 95% confidence interval (CI) 28.1, 34.7) and the age group 60-64 displayed the highest crude mortality rate (58.9 deaths per 1000 person-years; 95% CI 42.2, 75.5). Kaplan-Meier survival estimates indicated that nonelderly patients had better survival than elderly patients (P < 0.001). Adjusted Weibull analysis indicated that elderly age status was importantly associated (adjusted hazard ratio 1.23, 95% CI 1.08-1.42) with mortality, when controlling for sex, baseline CD4+ cell count and year of therapy initiation. Conclusion: As antiretroviral treatment cohorts mature, the proportion of patients who are elderly will inevitably increase. Elderly patients may require focused clinical care that extends beyond HIV treatment. © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Authors & Co-Authors
Bakanda, Celestin
Uganda, Kampala
Aids Support Organization Uganda
Birungi, Josephine
Uganda, Kampala
Aids Support Organization Uganda
Mwesigwa, Robert
Uganda, Kampala
Aids Support Organization Uganda
Ford, Nathan P.
Canada, Burnaby
Simon Fraser University
South Africa, Cape Town
University of Cape Town
Cooper, Curtis L.
Canada, Ottawa
L'hôpital D'ottawa
Au-Yeung, Christopher
Canada, Vancouver
The University of British Columbia
Chan, Keith J.
Canada, Vancouver
The University of British Columbia
Nachega, J. B.
South Africa, Stellenbosch
Stellenbosch University
Wood, Evan
Canada, Vancouver
The University of British Columbia
Hogg, Robert S.
Canada, Burnaby
Simon Fraser University
Canada, Vancouver
The University of British Columbia
Dybul, Mark R.
United States, Washington, D.c.
Georgetown Law
United States, Dallas
George W. Bush Institute
Mills, Edward J.
Uganda, Kampala
Aids Support Organization Uganda
Canada, Vancouver
The University of British Columbia
Canada, Ottawa
University of Ottawa
Statistics
Citations: 63
Authors: 12
Affiliations: 9
Identifiers
Doi:
10.1097/QAD.0b013e3283437ed7
e-ISSN:
14735571
Research Areas
Environmental
Infectious Diseases
Study Design
Cohort Study
Study Locations
Uganda